Ambu today said it received Health Canada clearance for its aScope 4 Cysto single-use cystoscope.
The cystoscope is a flexible, single-use endoscope that is designed to eliminate significant capital, repair and cleaning costs with a patient-ready instrument for every procedure, according to Ambu. The device is used for diagnosing, managing and treating lower urinary disorders such as hematuria, incontinence and bladder cancer.
Get the full story on our sister site, Medical Tubing + Extrusion.
Ambu received the award for its single-use flexible endoscopes that are designed to make the devices safe, affordable and accessible. It has aView and aBox all-in-one video displays that eliminate the traditional video endoscopy tower size and expense to be more cost-efficient, compact and portable platforms.
Frost & Sullivan presents the Global New Product Innovation Award to companies that develop an innovative element in a product with “leading-edge technologies.” The award recognizes the value-added features/benefits of a product and an increased return on investment the device gives to customers, according to Frost & Sullivan.
Get the full story on our sister site, Medical Tubing + Extrusion.
Ambu aScope Duodeno [Image courtesy Ambu]
Frost & Sullivan today announced that it awarded Ambu with a 2021 Global New Product Innovation Award.Ambu received the award for its single-use flexible endoscopes that are designed to make the devices safe, affordable and accessible. It has aView and aBox all-in-one video displays that eliminate the traditional video endoscopy tower size and expense to be more cost-efficient, compact and portable platforms.
Frost & Sullivan presents the Global New Product Innovation Award to companies that develop an innovative element in a product with “leading-edge technologies.” The award recognizes the value-added features/benefits of a product and an increased return on investment the device gives to customers, according to Frost & Sullivan.
Get the full story on our sister site, Medical Tubing + Extrusion.
Ambu (CPH:AMBU-B) announced today that it has secured national single-use endoscopy contract expansions with two major U.S. group purchasing organizations (GPOs).
Ballerup, Denmark–based Ambu is now on contract with all four major GPOs in the U.S. Customers served by the GPOs now have access to either a full or partial portfolio of single-use endoscopy categories.
Ambu’s aScope 4 Cysto has been added to one contract, while Ambu’s aScope Duodeno has been added on another.
“We’re very excited to see that GPOs, with existing contracts, are adding newly released products to expand the dedicated single-use endoscopy categories, serving hospitals and healthcare providers to provide a broader array of advanced single-use devices,” said Steven Block, president of Ambu’s North American business.
“In particular, our duodenoscope contract expansion will accelerate adoption of single-use endoscopy in GI and provide hospitals with additional opportunitie…
Luckily, several medical device companies have stepped in to solve the problems. (Here are five of the innovations.)
Duodenoscopes are flexible, lighted tubes threaded through the mouth, throat and stomach into the top of the small intestine. They’re an important tool for spotting problems such as lesions and tumors in the pancreatic duct and bile duct, but the devices are also complex, with many small working parts.
“Duodenoscopes – regardless of whether they are reusable or single-use – are one of the most technically complex flexible endoscopes to design and manufacture, as they travel deep into the body with a camera mounted on the side instead of the front,” David Pierce, EVP and president of MedSurg and president of e…
[Images from Boston Scientific, Ambu and Olmypus]
Duodenoscopes are important medical devices that are used for endoscopic retrograde cholangiopancreatography (ERCP) procedures. However, the devices have had serious problems in the past.Luckily, several medical device companies have stepped in to solve the problems.
Duodenoscopes are flexible, lighted tubes threaded through the mouth, throat and stomach into the top of the small intestine. They’re an important tool for spotting problems such as lesions and tumors in the pancreatic duct and bile duct, but the devices are also complex, with many small working parts.
“Duodenoscopes – regardless of whether they are reusable or single-use – are one of the most technically complex flexible endoscopes to design and manufacture, as they travel deep into the body with a camera mounted on the side instead of the front,” David Pierce, EVP and president of M…
[Images from Boston Scientific, Ambu and Olmypus]Duodenoscopes are important medical devices that are used for endoscopic retrograde cholangiopancreatography (ERCP) procedures. However, the devices have had serious problems in the past.
Luckily, several medical device companies have stepped in to solve the problems. (Here are five of the innovations.)
Duodenoscopes are flexible, lighted tubes threaded through the mouth, throat and stomach into the top of the small intestine. They’re an important tool for spotting problems such as lesions and tumors in the pancreatic duct and bile duct, but the devices are also complex, with many small working parts.
“Duodenoscopes – regardless of whether they are reusable or single-use – are one of the most technically complex flexible endoscopes to design and manufacture, as they travel deep into the body with a camera mounted on the side instead of the front,” David Pierce, EVP and president of MedSu…
Hospital closures connected to COVID-19 have cut into the sales of many medical device companies, but executives at rival makers of single-use scopes say pandemic has only heightened existing concerns about contamination, exposure and cost.
In interviews in this week’s DeviceTalks Weekly Podcast, executives from Ambu A/S and Boston Scientific (NYSE:BSX) said improved technology make single-use scopes as effective as reusable scopes without carrying the price tag or risk of infection traditional scopes require.
Steve Block, president of Ambu US, projected that over the next decade disposable scopes will account for a majority of devices sold, saying they’ll perform better than traditional devices, cost less, and eliminate the risk of infection. “There is just no reason to use a reusable product,” he said. He said Ambu has sold single-use scopes into 96% of the Top 500 hospitals in the US performing bronchoscopies.
Block appeared on the podcast alongside…
Ambu’s aScope Duodeno single-use duodenoscope [Image courtesy of Ambu]
Ambu announced that it was awarded a single-use endoscopy contract in the category of surgical disposable scopes with Premier Inc.Columbia, Md.-based Ambu said in a news release that it was also the only supplier of single-use endoscopes designated to participate in Premier’s Surpass and Ascend purchasing programs.
The three-year agreement creates a single-use endoscopy category specifically for the Premier membership, which, having been signed this week, becomes effective Nov. 1, 2020. Premier’s range of representation across 4,100 hospitals and health systems in the U.S., along with 200,000 other providers, is set to accelerate Ambu’s share of the single-use endoscope market, the company said.
Premier’s Surpass program offers $8.4 billion in annual supply chain purchasing with more than 30,000 ac…
Ambu’s aScope Duodeno single-use duodenoscope [Image courtesy of Ambu]
Ambu announced today that FDA has cleared its aScope Duodeno — a sterile, single-use duodenoscope meant to avoid the deadly superbug outbreaks that cropped up around reusable versions of the scopes.Other companies — including Boston Scientific (NYSE:BSX), Hoya’s (TYO:7741) Pentax subsidiary, and Olympus (TYO:7733) — have been releasing either fully disposable duodenoscopes or duodenoscopes with disporable endcaps or disposable elevators.
Duodenoscopes provide a less invasive way than traditional surgery to drain fluids from pancreatic and biliary ducts blocked by cancerous tumors, gallstones or other gastrointestinal conditions — with an estimated 600,000 procedures conducted annually in the United States.
FDA has been pushing duodenoscope makers to change designs, and CMS has been working to speed up Medicare beneficiar…
Ambu announced that it entered into a partnership with Fuel Medical Group to combine marketing and strategy with the latter’s endoscope technologies.
Under the agreement, Columbia, Md.-based Ambu is set to offer Fuel Medical marketing, finance, digital strategy, development and recruiting services.
In return, Camas, Wash.-based Fuel Medical will offer its single-use endoscopes, which include rhinolaryngoscopes, bronchoscopes, duodenoscopes and advanced monitors that increase safety and efficiency.
Financial details and other specifics related to the partnership were not disclosed by either party involved.
“This is a perfect match that will enable both companies to expand their reach into new and growing markets,” said Ambu CEO Juan Jose Gonzalez said in a news release. “Fuel Medical has such a strong reputation as a leader in business advisory that it was difficult to overlook their success. We are thrilled with the partnership and see an in…